M0224 Pemivibart infusionIntravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring
Status X: statutory exclusion, not paid under the PFS.
3 of 3 payer prior-auth lists that name M0224 require prior authorization or set conditions: Cigna.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| Cigna | ACA/IFP | All | prior auth required | Sep 27, 2024 | Master Precertification List (For Health Care Providers) | |
| Cigna | Basic Standard | All | prior auth required | Sep 27, 2024 | Master Precertification List (For Health Care Providers) | |
| Cigna | Complete/PHS+/Preferred | All | prior auth required | Sep 27, 2024 | Master Precertification List (For Health Care Providers) |
M0224 appears in 2 coverage policies from Blue Cross & Blue Shield of Mississippi, Premera Blue Cross.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Blue Cross & Blue Shield of Mississippi | Treatment Of Coronavirus Disease 2019 Covid19 (L.2.01.431) | not covered | payer document | |
| Premera Blue Cross | Non-covered Services and Procedures Page | 17 of 30 | ∞ | not covered | Jun 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.